MeSH term
Frequency | Condition_Probility | Animals | 19 | 0.0 |
Humans | 176 | 0.0 |
Aged | 36 | 0.0 |
Female | 75 | 0.0 |
Malates/metabolism | 2 | 100.0 |
Male | 111 | 0.0 |
Middle Aged | 55 | 0.0 |
Mitochondria/*metabolism | 3 | 1.0 |
Muscle, Skeletal/*metabolism | 3 | 1.0 |
3-Hydroxyacyl CoA Dehydrogenases/analysis | 3 | 75.0 |
Adult | 98 | 0.0 |
Biopsy | 13 | 0.0 |
Body Composition | 5 | 2.0 |
Citrate (si)-Synthase/analysis | 9 | 81.0 |
Exercise Test | 11 | 4.0 |
Lactates/*blood | 4 | 19.0 |
Oxygen Consumption | 15 | 6.0 |
Research Support, Non-U.S. Gov't | 116 | 0.0 |
Citrate (si)-Synthase/metabolism | 50 | 79.0 |
Gene Expression Regulation | 2 | 0.0 |
Kinetics | 4 | 0.0 |
*Oxygen Consumption | 7 | 17.0 |
Physical Endurance | 5 | 16.0 |
Physical Fitness/*physiology | 4 | 11.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Aged, 80 and over | 6 | 0.0 |
Biological Markers/analysis | 2 | 0.0 |
Electron Transport Complex I | 3 | 8.0 |
Electron Transport Complex III/metabolism | 2 | 14.0 |
Electron Transport Complex IV/metabolism | 8 | 18.0 |
Enzyme Activation | 2 | 0.0 |
NADH, NADPH Oxidoreductases/metabolism | 2 | 7.0 |
Oxidoreductases/metabolism | 2 | 2.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 23 | 0.0 |
Succinate Dehydrogenase/metabolism | 7 | 20.0 |
3-Hydroxyacyl CoA Dehydrogenases/metabolism | 9 | 69.0 |
Comparative Study | 28 | 0.0 |
Glycolysis | 7 | 13.0 |
Muscle, Skeletal/enzymology/*metabolism | 4 | 40.0 |
Oxidation-Reduction | 10 | 0.0 |
Phosphofructokinases/metabolism | 3 | 75.0 |
Sex Characteristics | 2 | 0.0 |
Adenosine Diphosphate/metabolism | 2 | 3.0 |
Adenosine Triphosphate/metabolism | 6 | 1.0 |
In Vitro | 2 | 0.0 |
Isometric Contraction/physiology | 2 | 16.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Oxygen Consumption/*physiology | 3 | 9.0 |
Phosphocreatine/metabolism | 5 | 29.0 |
Asthma/*blood/drug therapy | 2 | 40.0 |
Immunosuppressive Agents/administration & dosage | 2 | 7.0 |
Molecular Sequence Data | 7 | 0.0 |
Pedigree | 4 | 0.0 |
Syndrome | 3 | 0.0 |
Age Factors | 11 | 0.0 |
Incidence | 2 | 0.0 |
Creatine Kinase/metabolism | 8 | 22.0 |
Cross-Sectional Studies | 2 | 0.0 |
Energy Metabolism/*physiology | 3 | 3.0 |
L-Lactate Dehydrogenase/metabolism | 21 | 14.0 |
Muscle, Skeletal/*physiopathology | 2 | 12.0 |
Reference Values | 3 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Genotype | 2 | 0.0 |
*Germ-Line Mutation | 4 | 0.0 |
Hamartoma Syndrome, Multiple/*genetics | 3 | 10.0 |
Phenotype | 6 | 0.0 |
Phosphoric Monoester Hydrolases/*genetics | 5 | 2.0 |
Prospective Studies | 5 | 0.0 |
Anaerobiosis | 2 | 8.0 |
Body Mass Index | 2 | 0.0 |
Creatine Kinase/analysis | 2 | 15.0 |
Energy Metabolism | 6 | 3.0 |
English Abstract | 8 | 0.0 |
Follow-Up Studies | 6 | 0.0 |
L-Lactate Dehydrogenase/analysis | 5 | 13.0 |
Lung Diseases, Obstructive/*metabolism | 2 | 28.0 |
Oxygen/blood | 2 | 1.0 |
Phosphofructokinase-1/analysis | 3 | 75.0 |
Respiratory Function Tests | 3 | 1.0 |
Adolescent | 16 | 0.0 |
Cells, Cultured | 12 | 0.0 |
Child | 7 | 0.0 |
Child, Preschool | 8 | 0.0 |
European Continental Ancestry Group | 2 | 0.0 |
Immunosuppressive Agents/pharmacology | 2 | 1.0 |
Lymphocyte Culture Test, Mixed | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Gene Expression | 4 | 0.0 |
Hela Cells | 3 | 0.0 |
Muscle, Skeletal/metabolism | 5 | 2.0 |
Rats | 7 | 0.0 |
Transfection | 3 | 0.0 |
Biological Markers/blood | 2 | 0.0 |
*DNA Repair | 2 | 0.0 |
Mutation | 4 | 0.0 |
Oxygen/metabolism | 4 | 1.0 |
*Transcription, Genetic | 2 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Blotting, Western | 5 | 0.0 |
DNA, Mitochondrial/analysis | 2 | 22.0 |
Infant, Newborn | 4 | 0.0 |
Carbohydrate Sequence | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
*Tumor Suppressor Proteins | 5 | 0.0 |
Drug Therapy, Combination | 3 | 0.0 |
*Kidney Transplantation | 2 | 0.0 |
Adaptation, Physiological | 6 | 6.0 |
Blood Glucose/metabolism | 2 | 0.0 |
Body Composition/physiology | 2 | 3.0 |
Glycogen/metabolism | 4 | 8.0 |
Oxygen Consumption/physiology | 5 | 7.0 |
Physical Endurance/*physiology | 4 | 9.0 |
Base Sequence | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Citrate (si)-Synthase/*metabolism | 12 | 100.0 |
Electron Transport Complex IV/*metabolism | 4 | 23.0 |
Heart Transplantation | 2 | 5.0 |
*Oxidative Phosphorylation | 2 | 20.0 |
Stroke Volume | 2 | 3.0 |
*Adaptation, Physiological | 4 | 7.0 |
Bicycling/*physiology | 2 | 11.0 |
Blood/metabolism | 2 | 5.0 |
Glucose Tolerance Test | 4 | 0.0 |
Muscle, Skeletal/enzymology | 2 | 4.0 |
Osmolar Concentration | 2 | 0.0 |
*Exercise Therapy | 4 | 14.0 |
*Muscle Proteins | 2 | 0.0 |
Mice | 5 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Oxidative Phosphorylation | 3 | 8.0 |
Gene Deletion | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Malate Dehydrogenase/analysis | 3 | 27.0 |
Models, Biological | 2 | 0.0 |
Chromosome Deletion | 2 | 0.0 |
Anaerobic Threshold/physiology | 2 | 18.0 |
Enzymes/metabolism | 4 | 25.0 |
Cattle | 3 | 0.0 |
Cell Line | 5 | 0.0 |
*DNA Damage | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Oxidoreductases/*metabolism | 3 | 7.0 |
Creatine/metabolism | 2 | 14.0 |
*Energy Metabolism | 6 | 6.0 |
Heart/*physiopathology | 2 | 4.0 |
Body Composition/*physiology | 2 | 5.0 |
Densitometry, X-Ray | 2 | 1.0 |
Magnetic Resonance Spectroscopy | 3 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Citrate (si)-Synthase/*genetics | 3 | 100.0 |
Cloning, Molecular | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Adipose Tissue/anatomy & histology | 2 | 7.0 |
Aging/*metabolism | 3 | 1.0 |
Regression Analysis | 5 | 0.0 |
Body Weight | 2 | 0.0 |
Capillaries/anatomy & histology | 2 | 40.0 |
Adenosinetriphosphatase/metabolism | 3 | 2.0 |
*Carrier Proteins | 2 | 0.0 |
Exercise/*physiology | 7 | 1.0 |
Muscle, Skeletal/*enzymology | 3 | 6.0 |
Homozygote | 2 | 0.0 |
Time Factors | 7 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Blood Platelets/*enzymology | 2 | 2.0 |
Citrate (si)-Synthase/blood | 2 | 66.0 |
Electron Transport Complex IV/blood | 3 | 60.0 |
Mitochondria/*enzymology | 5 | 4.0 |
Hexokinase/metabolism | 4 | 26.0 |
Phosphofructokinase-1/metabolism | 13 | 52.0 |
Cell Survival/drug effects | 2 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
Pregnancy | 3 | 0.0 |
Insulin/*pharmacology | 2 | 0.0 |
Sex Factors | 4 | 0.0 |
Adenosine Triphosphate/*biosynthesis | 2 | 33.0 |
Bicycling | 2 | 15.0 |
Lactic Acid/metabolism | 2 | 7.0 |
Muscles/*metabolism | 4 | 5.0 |
*Physical Education and Training | 12 | 21.0 |
*Physical Endurance | 7 | 15.0 |
Muscle, Skeletal/*physiology | 2 | 2.0 |
Hexokinase/analysis | 3 | 42.0 |
Lactic Acid | 3 | 4.0 |
Flow Cytometry | 2 | 0.0 |
Phagocytosis | 2 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Molecular Weight | 3 | 0.0 |
Leg/*physiology | 2 | 18.0 |
Thigh | 3 | 10.0 |
Sequence Alignment | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Infant | 6 | 0.0 |
*Exertion | 8 | 5.0 |
Muscles/anatomy & histology/enzymology/*metabolism | 3 | 100.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Leg/physiology | 2 | 11.0 |
Exercise Tolerance | 2 | 13.0 |
Blood Glucose/analysis | 2 | 0.0 |
Fatty Acids, Nonesterified/blood | 2 | 1.0 |
Heart Rate | 3 | 1.0 |
Lactates/blood | 3 | 4.0 |
Biopsy, Needle | 3 | 0.0 |
Pyruvate Dehydrogenase Complex/metabolism | 3 | 16.0 |
Isoenzymes | 6 | 3.0 |
Muscles/enzymology/*metabolism | 3 | 60.0 |
Myocardium/enzymology/*metabolism | 2 | 14.0 |
Myoglobin/*metabolism | 3 | 100.0 |
Leg | 4 | 9.0 |
Adenylate Kinase/metabolism | 3 | 50.0 |
Cyclosporins/adverse effects/*therapeutic use | 2 | 40.0 |
Drug Resistance | 2 | 0.0 |
Glomerulonephritis/*drug therapy | 2 | 40.0 |
Monocytes/drug effects/*metabolism | 2 | 1.0 |
Muscles/*enzymology | 14 | 17.0 |
3-Hydroxyacyl CoA Dehydrogenases/*metabolism | 3 | 50.0 |
L-Lactate Dehydrogenase/*metabolism | 6 | 42.0 |
*Muscle Contraction | 3 | 9.0 |
Oxo-Acid-Lyases/*metabolism | 8 | 100.0 |
*Sports | 3 | 9.0 |
Creatine Kinase/*metabolism | 2 | 15.0 |
Thromboplastin/*biosynthesis | 2 | 2.0 |
Histocytochemistry | 2 | 0.0 |
Plasmids | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism | 3 | 14.0 |
Myocardium/*enzymology | 6 | 7.0 |
Myoglobin/metabolism | 2 | 33.0 |
Papillary Muscles/enzymology | 2 | 100.0 |
Ubiquinone/*analogs & derivatives/metabolism | 2 | 100.0 |
Lung Diseases, Obstructive/*enzymology/physiopathology | 2 | 100.0 |
Aspartate Aminotransferases/metabolism | 3 | 16.0 |
Biological Transport | 2 | 0.0 |
Malate Dehydrogenase/metabolism | 3 | 17.0 |
Muscles/anatomy & histology/*enzymology | 2 | 100.0 |
Brain/*metabolism | 2 | 0.0 |
Cerebroside-Sulfatase/*deficiency | 2 | 66.0 |
Sulfoglycosphingolipids/metabolism | 2 | 22.0 |
Life Style | 2 | 1.0 |
Trace Elements/*analysis | 2 | 50.0 |
Exertion | 2 | 2.0 |
*Physical Fitness | 2 | 5.0 |
Capillaries/physiology | 2 | 10.0 |
Mitochondria, Muscle/enzymology | 2 | 18.0 |
Physical Fitness | 2 | 8.0 |
Energy Metabolism/physiology | 2 | 3.0 |
*Chromosomes, Human, 6-12 and X | 2 | 1.0 |
Oxo-Acid-Lyases/*genetics | 2 | 66.0 |
Acute Disease | 2 | 0.0 |
Alcohol Oxidoreductases/analysis | 2 | 100.0 |
Coenzyme A | 2 | 100.0 |
Glyceraldehyde-3-Phosphate Dehydrogenases/analysis | 2 | 50.0 |
Glycerolphosphate Dehydrogenase/analysis | 2 | 66.0 |
Hydroxy Acids | 2 | 100.0 |
